Overview

Ozanimod in Patients With Alzheimer's Disease

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the benefits of ozanimod in patients with moderate Alzheimer's disease.
Phase:
PHASE2
Details
Lead Sponsor:
ChenXiaoChun
Collaborator:
Fujian Medical University Union Hospital
Treatments:
ozanimod